DataLibraryResearch is tracking the market dynamics of the crisis in the Pharma & Healthcare industry amid lock-down changes in the supply chain.

Get detailed analysis of the COVID-19 impact on the Life Science Analytics Market

Global Life Science Analytics Market Opportunities and Forecast 2020-2027

  • DLR2807
  • 08 September, 2021
  • Pharma & Healthcare
  • Pages: 120
  • Global
Global Life Science Analytics Market, By Type (Descriptive Analytics, Predictive Analytics, Prescriptive Analytics), By End Use (Pharmaceutical & Biotechnology Companies, Medical Device Companies, Research Centers ,Third-party Administrators)and By Application (Research & Development ,Preclinical Trials ,Clinical Trials ,Sales & Marketing ,Regulatory Compliance ,Supply Chain Optimization, Pharmacovigilance) and opportunities and forecast 2020-2027

Life Science Analytics Market Overview

Over the previous couple of years, pharmaceutical companies are increasingly considering digitization as a strategic initiative which will potentially help transform different components of their value chain to become more productive and profitable. With the assistance of digital technologies, like mobility and pervasive computing, big data, and analytics, companies can effectively improve their R&D productivity, manufacturing capabilities, sales and marketing effectiveness, and compliance management. In manufacturing processes, analytics technologies are being integrated to capture unit operations data automatically, and in R&D, numerous labs are going paperless. This approach has helped reduce process times and minimize errors.

High costs make these solutions less affordable for small- and medium-sized pharma and biotech companies and CROs with limited budgets, thereby limiting their adoption. This trend is especially evident in emerging economies, where it's always a struggle to secure budgets for IT over medical equipment.
 
Covid-19 Impact on Life Science Analytics Market:

In addition, the current Global Market study offers a detailed analysis of the current COVID-19 pandemic impact on the market growth and its influence on the future growth of the Global Market. The recently published report demonstrates the elevation in the demand for the healthcare sector. The healthcare manufacturers have experienced long term as well as short term effect which includes supply shortages, panic buying and stocking, regulation changes as short-term whereas approval delays and possible trend variations in consumption could be perceived as long-term impacts of COVID-19 on the health and pharmaceutical market.

The increasing need for a cure has pushed vaccine research and manufacturers to the limit. In addition to this, panic conditions have already spurred the demand for many healthcare products and services which are discussed in detail in this report. Moreover, the impact of COVID-19 on overall market revenue for the base year 2020 and its projection up to 2027 is provided in detail in this report.
 
Life Science Analytics Market Segment Overview

Based on type, the descriptive analytics segment accounted for the largest market share in forecast period. This will be attributed to the many usage of descriptive analytics by life science stakeholders to realize a far better understanding of the past trends and events occurring in real-time.

Based on application, the sales & marketing segment is predicted to grow at the best CAGR during the forecast period. The high growth of this segment is often attributed to the increasing adoption of analytics by life science companies to align their sales & marketing campaigns. The growing importance of post-marketing surveillance is additionally boosting the use of analytics for sales & marketing.

Based on end-users, the pharmaceutical & biotechnology companies segment commanded the most important share of the life science analytics market in 2019. This will be attributed to the high utilization of analytics solutions by pharmaceutical & biotechnology companies.

Market Analysis, Insights and Forecast – By Type
·       Descriptive Analytics
·       Predictive Analytics
·       Prescriptive Analytics

Market Analysis, Insights and Forecast – By End Use
·       Pharmaceutical & Biotechnology Companies
·       Medical Device Companies
·       Research Centers
·       Third-party Administrators
 
Market Analysis, Insights and Forecast – By Application
·       Research & Development
·       Preclinical Trials
·       Clinical Trials
·       Sales & Marketing
·       Regulatory Compliance
·       Supply Chain Optimization
·       Pharmacovigilance
 
Life Science Analytics Market Regional Overview

Region-wise, in terms of regions, North America accounted for the largest share of the market, followed by Europe. However, Asia is predicted to grow at the best CAGR during the forecast period due to the increasing prevalence of chronic diseases, growth of the bioscience industry, rising adoption of advanced technologies, and therefore the growing focus of major players on increasing their presence in emerging Asian countries.

Life Science Analytics Market, By Geography

·       North America (US & Canada)
·       Europe (UK, Germany, France, Italy, Spain, & Rest of Europe)
·       Asia-Pacific (Japan, China, India, Australia, & South Korea, & Rest of Asia-Pacific)
·       LAMEA (Brazil, Saudi Arabia, UAE & Rest of LAMEA)
 
Life Science Analytics Market Competitor overview

Some key developments and strategies adopted by manufacturers in the Life Science Analytics are highlighted below.
 
·        In February 2020, IQVIA had launched Avacare Clinical Research Network that's a global-based site network, which might help provide more opportunities and patient options for clinical trials.
 
Life Science Analytics Market, Key Players

·       Accenture
·       SAS Institute Inc.
·       IBM Corporation
·       IQVIA
·       Wipro
·       Cognizant
·       SCIO Health Analytics
·       Allscripts Healthcare Solutions
·       Cerner Corporation
·       Microsoft
·       Infosys Limited
·       MaxisIT
·       Optum
·       Cotiviti
·       Oracle Corporation
 

Life Science Analytics Market Study Global Market Analysis, Insights and Forecast, 2020-2027

    1. Introduction

    • 1.1. Research Scope
    • 1.2. Market Segmentation
    • 1.3. Research Methodology
    • 1.4. Definitions and Assumptions

    2. Executive Summary

      3. Market Dynamics

      • 3.1. Market Drivers
      • 3.2. Market Restraints
      • 3.3. Market Opportunities

      4. Key Insights

      • 4.1. Key Emerging Trends – For Major Countries
      • 4.2. Latest Technological Advancement
      • 4.3. Regulatory Landscape
      • 4.4. Industry SWOT Analysis
      • 4.5. Porters Five Forces Analysis

      5. Global Life Science Analytics Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 5.1. Key Findings / Summary
      • 5.2. Market Analysis, Insights and Forecast – By Type
        • 5.2.1. Descriptive Analytics
        • 5.2.2. Predictive Analytics
        • 5.2.3. Prescriptive Analytics
      • 5.3. Market Analysis, Insights and Forecast – By End Use
        • 5.3.1. Pharmaceutical & Biotechnology Companies
        • 5.3.2. Medical Device Companies
        • 5.3.3. Research Centers
        • 5.3.4. Third-party Administrators
      • 5.4. Market Analysis, Insights and Forecast – By Application
        • 5.4.1. Research & Development
        • 5.4.2. Preclinical Trials
        • 5.4.3. Clinical Trials
        • 5.4.4. Sales & Marketing
        • 5.4.5. Regulatory Compliance
        • 5.4.6. Supply Chain Optimization
        • 5.4.7. Pharmacovigilance
      • 5.5. Market Analysis, Insights and Forecast – By Region
        • 5.5.1. North America
        • 5.5.2. Europe
        • 5.5.3. Asia Pacific
        • 5.5.4. Latin America, Middle East, and Africa

      6. North America Life Science Analytics Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 6.1. Key Findings / Summary
      • 6.2. Market Analysis, Insights and Forecast – By Type
        • 6.2.1. Descriptive Analytics
        • 6.2.2. Predictive Analytics
        • 6.2.3. Prescriptive Analytics
      • 6.3. Market Analysis, Insights and Forecast – By End Use
        • 6.3.1. Pharmaceutical & Biotechnology Companies
        • 6.3.2. Medical Device Companies
        • 6.3.3. Research Centers
        • 6.3.4. Third-party Administrators
      • 6.4. Market Analysis, Insights and Forecast – By Application
        • 6.4.1. Research & Development
        • 6.4.2. Preclinical Trials
        • 6.4.3. Clinical Trials
        • 6.4.4. Sales & Marketing
        • 6.4.5. Regulatory Compliance
        • 6.4.6. Supply Chain Optimization
        • 6.4.7. Pharmacovigilance
      • 6.5. Market Analysis, Insights and Forecast – By Country
        • 6.5.1. U.S.
        • 6.5.2. Canada

      7. Europe Life Science Analytics Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 7.1. Key Findings / Summary
      • 7.2. Market Analysis, Insights and Forecast – By Type
        • 7.2.1. Descriptive Analytics
        • 7.2.2. Predictive Analytics
        • 7.2.3. Prescriptive Analytics
      • 7.3. Market Analysis, Insights and Forecast – By End Use
        • 7.3.1. Pharmaceutical & Biotechnology Companies
        • 7.3.2. Medical Device Companies
        • 7.3.3. Research Centers
        • 7.3.4. Third-party Administrators
      • 7.4. Market Analysis, Insights and Forecast – By Application
        • 7.4.1. Research & Development
        • 7.4.2. Preclinical Trials
        • 7.4.3. Clinical Trials
        • 7.4.4. Sales & Marketing
        • 7.4.5. Regulatory Compliance
        • 7.4.6. Supply Chain Optimization
        • 7.4.7. Pharmacovigilance
      • 7.5. Market Analysis, Insights and Forecast – By Country
        • 7.5.1. UK
        • 7.5.2. Germany
        • 7.5.3. France
        • 7.5.4. Italy
        • 7.5.5. Spain
        • 7.5.6. Russia
        • 7.5.7. Rest of Europe

      8. Asia Pacific Life Science Analytics Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 8.1. Key Findings / Summary
      • 8.2. Market Analysis, Insights and Forecast – By Type
        • 8.2.1. Descriptive Analytics
        • 8.2.2. Predictive Analytics
        • 8.2.3. Prescriptive Analytics
      • 8.3. Market Analysis, Insights and Forecast – By End Use
        • 8.3.1. Pharmaceutical & Biotechnology Companies
        • 8.3.2. Medical Device Companies
        • 8.3.3. Research Centers
        • 8.3.4. Third-party Administrators
      • 8.4. Market Analysis, Insights and Forecast – By Application
        • 8.4.1. Research & Development
        • 8.4.2. Preclinical Trials
        • 8.4.3. Clinical Trials
        • 8.4.4. Sales & Marketing
        • 8.4.5. Regulatory Compliance
        • 8.4.6. Supply Chain Optimization
        • 8.4.7. Pharmacovigilance
      • 8.5. Market Analysis, Insights and Forecast – By Country
        • 8.5.1. China
        • 8.5.2. India
        • 8.5.3. Japan
        • 8.5.4. Australia
        • 8.5.5. South East Asia
        • 8.5.6. Rest of Asia Pacific

      9. Latin America, Middle East, and Africa Life Science Analytics Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 9.1. Key Findings / Summary
      • 9.2. Market Analysis, Insights and Forecast – By Type
        • 9.2.1. Descriptive Analytics
        • 9.2.2. Predictive Analytics
        • 9.2.3. Prescriptive Analytics
      • 9.3. Market Analysis, Insights and Forecast – By End Use
        • 9.3.1. Pharmaceutical & Biotechnology Companies
        • 9.3.2. Medical Device Companies
        • 9.3.3. Research Centers
        • 9.3.4. Third-party Administrators
      • 9.4. Market Analysis, Insights and Forecast – By Application
        • 9.4.1. Research & Development
        • 9.4.2. Preclinical Trials
        • 9.4.3. Clinical Trials
        • 9.4.4. Sales & Marketing
        • 9.4.5. Regulatory Compliance
        • 9.4.6. Supply Chain Optimization
        • 9.4.7. Pharmacovigilance
      • 9.5. Market Analysis, Insights and Forecast – By Country
        • 9.5.1. Brazil
        • 9.5.2. Saudi Arabia
        • 9.5.3. UAE
        • 9.5.4. Rest of LAMEA

      10. Competitive Analysis

      • 10.1. Company Market Share Analysis, 2018
      • 10.2. Key Industry Developments
      • 10.3. Company Profile
      • 10.4. Accenture
        • 10.4.1. Business Overview
        • 10.4.2. Segment 1 & Service Offering
        • 10.4.3. Overall Revenue
        • 10.4.4. Geographic Presence
        • 10.4.5. Recent Development
      *Similar details will be provided for the following companies
      • 10.5. SAS Institute Inc.
      • 10.6. IBM Corporation
      • 10.7. IQVIA
      • 10.8. Wipro
      • 10.9. Cognizant
      • 10.10. SCIO Health Analytics
      • 10.11. Allscripts Healthcare Solutions
      • 10.12. Cerner Corporation
      • 10.13. Microsoft
      • 10.14. Infosys Limited
      • 10.15. MaxisIT
      • 10.16. Optum
      • 10.17. Cotiviti

      Report You Might be Interested

      Choose License Type

      • USD
      • GBP
      • EURO
      • INR
      Credit card Logo

      Happy To Assist You

      Have a Question? email us at

      info@datalibraryresearch.com

      Or Call Us On

      US +1 360 851 1343

      IND +91 880 579 4934